Rceiving chemotherapy not associated with survival benefit. »
03/19/19

Each calculator demonstrated superior discriminatory ability compared with clinical staging. »
05/23/18

EGFR promoter essential for EVI regulation of EGFR expression. »
08/11/19

EGFR inhibitors significantly reduced number of residual cancer cells after cytotoxic anticancer drug. »
05/22/19

Increased levels of 2 miRNAs and hemoglobin in feces can identify patients with AAs or CRC. »
06/25/19

Cumulative CIN3+ incidence among triage positive women lower. »
03/19/19

Risk discrimination for interval breast cancers could be doubled by instead using breast density, BMI, family history and hormonal exposure. »
07/29/19

Monoclonal antibodies against proteins or their inhibitors used for treatment. »
04/04/19

Women with low density constituted heterogenous group. »
10/17/19

Observed variations in CIMP-H prevalence across countries. »
10/17/19